IndraLab

Statements

Aprepitant inhibits ITCH. 1 / 1

| 1

reach

"Aprepitant at 80 mg o.d. for 1 week was shown to significantly reduce chronic itch of various etiologies, especially in patients with prurigo nodularis and atopic predisposition."

22418939

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Aprepitant inhibits ITCH. 1 / 1

INDRA sources:

Databases

Reading